Spotlight Series on Hepatitis C

HCV 101: Prevalence of Hepatitis C Virus in the United States

June 2004

This article is part of The Body PRO's archive. Because it contains information that may no longer be accurate, this article should only be considered a historical document.

The following table is adapted from the Centers for Disease Control and Prevention's HCV Web-based training course "Hepatitis C: What Clinicians and Other Health Professionals Need to Know." The text is based upon the Recommendations for Prevention and Control of Hepatitis C Virus (HCV) Infection and HCV-related Chronic Disease (Centers for Disease Control and Prevention. MMWR 1998; 47 [No. RR-19]).

Table 1. Estimated Average Prevalence of Hepatitis C Virus (HCV) Infection in the United States by Various Characteristics and Estimated Prevalence of Persons With These Characteristics in the Population
 HCV-Infection PrevalencePrevalence of Persons With Characteristic, %
%(range, %) 
Persons with hemophilia treated with products made before 198787(74-90)<0.01
Injecting drug users
   history of prior use

No Data


Persons with abnormal alanine aminotransferase levels15(10-18)5
Chronic hemodialysis patients10(0-64)0.1
Persons with multiple
sex partners (lifetime)



Persons reporting a history of sexually transmitted diseases6(1-10)17
Persons receiving blood transfusions before 19906(5-9)6
Infants born to infected mothers5(0-25)0.1
Men who have sex with men4(2-18)5
General population1.8(1.5-2.3)NA*
Healthcare workers1(1-2)9
Pregnant women1--1.5
Military personnel0.3(0.2-0.4)0.5
Volunteer blood donors0.16--5
* Not applicable

This article was provided by Brown Medical School. It is a part of the publication HEPP Report.


The content on this page is free of advertiser influence and was produced by our editorial team. See our content and advertising policies.